fosinopril has been researched along with Diabetic Nephropathies in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, A; Dubey, GP; Ghosh, B; Rajak, M; Singh, RG | 1 |
| Cui, W; Hu, L; Huang, H; Lin, J; Xu, W; Zhu, X | 1 |
| Deng, JL; Hou, YB; Li, J; Wang, H; Yue, J | 1 |
| Lan, H; Li, P; Liang, Q; Lu, J; Luo, G; Wang, Y; Yin, T; Zhang, H; Zhang, X; Zhao, T | 1 |
| Bicket, DP | 1 |
| Huang, YH; Shen, W; Wang, HT; Wang, Y; Zhang, H; Zhu, QZ | 1 |
| Chan, JC; Chan, WB; Chow, CC; Cockram, CS; Ko, GT; Lee, KF; Lo, MK; Ma, RC; Ozaki, R; So, WY; Tong, PC | 1 |
| Basi, S; Fesler, P; Lewis, JB; Mimran, A | 1 |
| Batlle, D; Keilani, T; Schlueter, W | 1 |
| García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
4 review(s) available for fosinopril and Diabetic Nephropathies
| Article | Year |
|---|---|
Prostaglandin E1 for preventing the progression of diabetic kidney disease.
Topics: Albuminuria; Alprostadil; Diabetic Nephropathies; Disease Progression; Drugs, Chinese Herbal; Fosinopril; Humans; Losartan; Proteinuria; Randomized Controlled Trials as Topic; Vasodilator Agents | 2010 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?
Topics: Albuminuria; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Prevalence; Proteinuria | 2008 |
Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Fosinopril; Humans; Lipids; Lipoproteins; Potassium; Proteinuria; Renin-Angiotensin System | 1995 |
2 trial(s) available for fosinopril and Diabetic Nephropathies
| Article | Year |
|---|---|
Comparative evaluation of fosinopril and herbal drug Dioscorea bulbifera in patients of diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Diabetic Nephropathies; Dioscorea; Disease Progression; Female; Fosinopril; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phytotherapy; Plant Extracts; Prospective Studies; Proteinuria | 2013 |
The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fosinopril; Humans; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome | 2006 |
4 other study(ies) available for fosinopril and Diabetic Nephropathies
| Article | Year |
|---|---|
Effect of fosinopril on chemerin and VEGF expression in diabetic nephropathy rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Chemokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Fosinopril; Intercellular Signaling Peptides and Proteins; Kidney; Male; Rats; Vascular Endothelial Growth Factor A | 2015 |
Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fosinopril; Gas Chromatography-Mass Spectrometry; Humans; Hypertrophy; Kidney Cortex; Male; Metabolomics; Proteinuria; Rats; Rats, Wistar; Toxins, Biological | 2012 |
[Combination therapy with losartan and fosinopril for early diabetic nephropathy].
Topics: Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Drug Therapy, Combination; Fosinopril; Humans; Losartan | 2003 |
Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Glucose; Blood Pressure; Body Weight; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Epoprostenol; Fosinopril; Kidney Glomerulus; Male; Multivariate Analysis; Rats; Rats, Wistar | 1997 |